Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in ...

The litigation has cast such a pall over Bayer that Anderson is considering whether to stop making glyphosate. The company ...

In a new lawsuit, Bayer aims to get AIG to shoulder costs from its legal crises, based on past insurance allegedly held by ...

Bayer (BAYRY) announced initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to block ...

The study drug BAY 3401016 is a monoclonal antibody that blocks a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport Syndrome (AS). By ...

Illinois and West Virginia have settled with Bayer unit Monsanto over claims the company knowingly contaminated the states’ ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Bayer reported positive results in a late-stage trial of an experimental stroke prevention medicine, sending ...

DEAR DR. ROACH: My wife and I are both healthy and in our 70s. At 5 feet, 9 inches tall, we are both at a reasonable weight. Our yearly blood panels always come back with good results. We both take ...

For months now, Bayer has been hinting, then openly threatening, to pull its signature product Roundup from the market altogether in response to the tsunami of lawsuits alleging its key ingredient, ...

Native healers have been using the salicylates found in willow bark for thousands of years. Hippocrates, often described as the father of modern medicine, wrote about a powder from willow to control a ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing business struggles and litigation headwinds, with significant upside potential if challenges are resolved. Bayer's Q2 '25 results ...